Life Sciences venture funding drops 22% in Q1
Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, decreased 22% during the first quarter of 2012 from the prior quarter, according to a new PwC US report, “Mixed Momentum.”
Like what you've read?
Forward to a friend!